Developing milk-inspired therapeutics for infectious diseases
Antimicrobial resistance and a lack of effective treatments are driving severe bacterial infections and recurrent dysbiosis-related conditions such as bacterial vaginosis.
Matrubials develops therapeutics derived from human milk peptides to create anti-infective treatments for infectious diseases, starting with bacterial vaginosis.
Clinicians and healthcare providers treating women of reproductive age and other patients with bacterial infections.
Bruce is a PhD from Cornell University, Distinguished Professor at the University of California, Davis and director of the Foods for Health Institute. His research focuses on the evolution of lactation and the biological mechanisms by which milk supports the growth, development and performance of infants. He is a co-founder of companies into the therapeutic health space: Evolve Biosystems, BCD Bioscience, Digestiva Inc. and Matrubials.
Dr. Carlito B. Lebrilla is a Distinguished Professor at the University of California, Davis in the Department of Chemistry and Biochemistry and Molecular Medicine in the School of Medicine. His research is in Analytical Chemistry focused on mass spectrometry with applications to clinical glycoproteomic and biofunctional food. He has co-founded startups in Food and Biotechnology including Evolve Biosystems, BCD Bio and InterVenn.
David A. Mills is a Professor in the Department of Food Science & Technology at the UC Davis. Dr. Mills studies the molecular biology and ecology of bacteria that play an active role in gut health or fermented foods. He is the Peter J. Shields Endowed Chair (2012), a Fellow in the American Academy of Microbiology (2015), and has been named a Highly Cited Researcher by Clarivate Analytics since 2018. He is also a co-founder of three start ups; Evolve Biosystems, BCD Bioscience, and Matrubials.


